Patents by Inventor Takeshe Imamura

Takeshe Imamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
    Patent number: 8012704
    Abstract: The invention relates to the molecule referred to as ALK-1, and its role as a type I receptor for members of the TGF-? family. The molecule has a role in the phosphorylation of Smad-5 and Smad1, which also act as activators of certain genes. Aspects of the invention relate to this interaction.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: September 6, 2011
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Kohei Miyazono, Takeshe Imamura, Peter ten Dijke
  • Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
    Publication number: 20100317011
    Abstract: The invention relates to the molecule referred to as ALK-1, and its role as a type I receptor for members of the TGF-? family. The molecule has a role in the phosphorylation of Smad-5 and Smad1, which also act as activators of certain genes. Aspects of the invention relate to this interaction.
    Type: Application
    Filed: July 6, 2010
    Publication date: December 16, 2010
    Inventors: Kohei Miyazono, Takeshe Imamura, Peter ten Dijke
  • Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
    Publication number: 20080131910
    Abstract: The invention relates to the molecule referred to as ALK-1, and its role as a type I receptor for members of the TGF-? family. The molecule has a role in the phosphorylation of Smad-5 and Smad1, which also act as activators of certain genes. Aspects of the invention relate to this interaction.
    Type: Application
    Filed: October 30, 2007
    Publication date: June 5, 2008
    Inventors: Kohei Miyazono, Takeshe Imamura, Peter ten Duke
  • Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
    Publication number: 20050048607
    Abstract: The invention relates to the molecule referred to as ALK-1, and its role as a type I receptor for members of the TGF-? family. The molecule has a role in the phosphorylation of Smad-5 and Smad1, which also act as activators of certain genes. Aspects of the invention relate to this interaction.
    Type: Application
    Filed: December 19, 2003
    Publication date: March 3, 2005
    Inventors: Kohei Miyazono, Takeshe Imamura, Peter Dijke
  • Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
    Patent number: 6692925
    Abstract: The invention relates to the molecule referred to as ALK-1, and its role as a type I receptor for members of the TGF-&bgr; family. The molecule has a role in the phosphorylation of Smad-5 and Smad1, which also act as activators of certain genes. Aspects of the invention relate to this interaction.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: February 17, 2004
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Kohei Miyazono, Takeshe Imamura, Peter ten Dijke